JP2020524509A5 - - Google Patents

Download PDF

Info

Publication number
JP2020524509A5
JP2020524509A5 JP2019570475A JP2019570475A JP2020524509A5 JP 2020524509 A5 JP2020524509 A5 JP 2020524509A5 JP 2019570475 A JP2019570475 A JP 2019570475A JP 2019570475 A JP2019570475 A JP 2019570475A JP 2020524509 A5 JP2020524509 A5 JP 2020524509A5
Authority
JP
Japan
Prior art keywords
nos
seq
determining
sample
mirna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019570475A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020524509A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/036377 external-priority patent/WO2018236589A1/en
Publication of JP2020524509A publication Critical patent/JP2020524509A/ja
Publication of JP2020524509A5 publication Critical patent/JP2020524509A5/ja
Pending legal-status Critical Current

Links

JP2019570475A 2017-06-19 2018-06-07 アルツハイマー病の診断のための循環血清マイクロｒｎａバイオマーカー及び方法 Pending JP2020524509A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762521768P 2017-06-19 2017-06-19
US62/521,768 2017-06-19
PCT/US2018/036377 WO2018236589A1 (en) 2017-06-19 2018-06-07 CIRCULATING SERIES MICRO-RNA BIOMARKERS AND METHODS OF DIAGNOSING ALZHEIMER'S DISEASE

Publications (2)

Publication Number Publication Date
JP2020524509A JP2020524509A (ja) 2020-08-20
JP2020524509A5 true JP2020524509A5 (https=) 2021-07-29

Family

ID=62952378

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019570475A Pending JP2020524509A (ja) 2017-06-19 2018-06-07 アルツハイマー病の診断のための循環血清マイクロｒｎａバイオマーカー及び方法

Country Status (5)

Country Link
US (3) US11634775B2 (https=)
EP (2) EP3642366B1 (https=)
JP (1) JP2020524509A (https=)
ES (2) ES3058210T3 (https=)
WO (1) WO2018236589A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020000293A (es) * 2017-07-12 2020-07-22 Univ Texas Tech System Microrna-455-3p como un marcador bioperiferico para la enfermedad de alzheimer.
CN111073973A (zh) * 2019-12-10 2020-04-28 石河子大学 一种用于早期诊断2型糖尿病的microRNA序列及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009009457A1 (en) * 2007-07-06 2009-01-15 University Of Louisville Research Foundation, Inc. Alzheimer's disease-specific micro-rna microarray and related methods
US20120108650A1 (en) * 2010-10-29 2012-05-03 Emory University Micro rna markers and methods related thereto
BR112013033488B8 (pt) 2011-06-27 2022-11-22 Eisai R&D Man Co Ltd Métodos para facilitar o diagnóstico do comprometimento cognitivo devido a doença de alzheimer ou comprometimento cognitivo leve (mci)e kit
CA2838562A1 (en) 2011-08-08 2013-02-14 Eugenia Wang Biomarker for alzheimer's disease and/or mild cognitively impairment, and use thereof
WO2013024469A1 (en) * 2011-08-16 2013-02-21 Rosetta Genomics Ltd. Methods and compositions for diagnosis of alzheimer's desease
JP6930832B2 (ja) 2013-11-18 2021-09-01 ディアミール, エルエルシーDiamir, Llc パーキンソン病（ＰＤ）の検出およびモニタリングのための、体液からのｍｉＲＮＡを使用する方法
WO2015179909A1 (en) * 2014-05-26 2015-12-03 The University Of Melbourne Mirna biomarkers of alzheimer's disease
ES2741591T3 (es) 2015-03-13 2020-02-11 Univ Hiroshima Método para ayudar a la detección de la enfermedad de Alzheimer o una discapacidad cognitiva moderada
EP3411500B9 (en) * 2016-02-05 2023-10-04 St. John's University Circulating serum microrna biomarkers and methods for determining parkinson's disease
US11149313B2 (en) * 2016-03-21 2021-10-19 Diamir, Llc Methods of using miRNAs from bodily fluids for detection and differentiation of neurodegenerative diseases

Similar Documents

Publication Publication Date Title
Zhang et al. Long noncoding RNA Cfast regulates cardiac fibrosis
JP5690588B2 (ja) 肝細胞癌のサブタイプを決定し、肝癌幹細胞を検出するための方法
WO2010023327A4 (en) Method for obtaining oligonucleotide aptamers and uses thereof
JP2019506183A5 (https=)
Zhou et al. Circulating exosomal microRNAs as emerging non‐invasive clinical biomarkers in heart failure: mega bio‐roles of a nano bio‐particle
Morán et al. Circulating levels of miR-150 are associated with poorer outcomes of A/H1N1 infection
JP7390002B2 (ja) 頭頸部がんの検出を補助する方法
JP6923215B2 (ja) 抗ｈｔｌｖ−１剤、ｈｔｌｖ−１関連脊髄症（ｈａｍ／ｔｓｐ）治療薬
JP6721189B2 (ja) ｖＷＦに結合するＤＮＡアプタマー
Duarte et al. Age-dependent effects of the recombinant spike protein/SARS-CoV-2 on the M–CSF–and IL-34-differentiated macrophages in vitro
Xu et al. Circular RNA CircCDKN2B− AS_006 promotes the tumor-like growth and metastasis of rheumatoid arthritis synovial fibroblasts by targeting the miR− 1258/RUNX1 Axis
Reza Etemadi et al. Gene expression patterns induced at different stages of rhinovirus infection in human alveolar epithelial cells
JP2020524509A5 (https=)
Nascimento et al. Global expression of noncoding RNome reveals dysregulation of small RNAs in patients with HTLV-1–associated adult T-cell leukemia: a pilot study
CN111214663A (zh) Tmed2在作为埃博拉病毒病治疗靶点中的应用
Reffsin et al. Single cell susceptibility to SARS-CoV-2 infection is driven by variable cell states
Jang et al. Molecular responses to the influenza A virus in chicken trachea-derived cells
Kim et al. An infectious cDNA clone of a growth attenuated Korean isolate of MERS coronavirus KNIH002 in clade B
CN106957905B (zh) 一种用于评估肿瘤免疫治疗效果的分子检测方法及引物组合物及试剂盒
WO2009116860A1 (en) Markers providing prognosis of metastasis among cancer patients
CN106148337B (zh) 长非编码rna ay927503及其用途
Tan et al. Long noncoding RNA-dependent regulation of vascular smooth muscle cell proliferation and migration in hypertension
JP2013521497A5 (https=)
JPWO2017082202A1 (ja) 抗ウイルス薬
JP7696809B2 (ja) インフルエンザウイルスの核酸アプタマー及び検出